Trial intelligence / Profile preview

Ciprofol vs Propofol in Painless Hysteroscopy

NCT06413862Not yet recruiting

Sponsor
Baoding No. 1 Central Hospital
Start
Aug 2024
Primary completion
Sep 2024
Modality
Allosteric Modulators
01

Overview

Randomised, double-blind trial of ciprofol in hysteroscopy (2 arms), sponsored by Baoding No. 1 Central Hospital. Primary endpoint: Injection pain at 24 hours. Planned start Aug 2024; status: not yet recruiting.

02

Drugs

ciprofol
03

Conditions

hysteroscopy

Beyond the preview

Go deeper on NCT06413862.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06413862.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call